Any speakers from Dana-Farber, Memorial Sloan-Kettering or UCLA?...

Any speakers from Dana-Farber, Memorial Sloan-Kettering or UCLA? AACR June program (plenary sessions).

PLENARY SESSIONSDISCOVERY SCIENCE PLENARY SESSION: MECHANISMS, IMPACT, AND EXPLOITATION OF CANCER CHROMOSOMAL INSTABILITY – DEDICATED TO THE MEMORY OF ANGELIKA AMONDavid Pellman, Dana-Farber Cancer Institute, Boston, Massachusetts Stephen P. Jackson, University of Cambridge, Cambridge, United KingdomKarlene A. Cimprich, Stanford University, Stanford, CaliforniaAdditional speaker to be announced
OPENING PLENARY SESSION: DISCOVERY SCIENCE DRIVING CLINICAL BREAKTHROUGHSCHAIR: CHARLES SWANTON, THE FRANCIS CRICK INSTITUTE, LONDON, UNITED KINGDOMJonathan S. Weissman, Whitehead Institute, Cambridge, MassachusettsKaren H. Vousden, The Francis Crick Institute, London, United Kingdom Matthew G. Vander Heiden, Massachusetts Institute of Technology, Cambridge, Massachusetts Melissa B. Davis, Weill Cornell Medical College, New York, New York Mark A. Dawson, Peter MacCallum Cancer Centre, Melbourne, Australia Zhijan James Chen, UT Southwestern Medical School, Dallas, Texas
UNDERSTANDING THE MOLECULAR AND MICROENVIRONMENTAL DETERMINANTS OF CANCERCHAIR: CHRISTINA CURTIS, STANFORD UNIVERSITY, STANFORD, CALIFORNIA Garry P. Nolan, Stanford University School of Medicine, Stanford, California Serena Nik-Zainal, University of Cambridge, Cambridge, United Kingdom Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York Jérôme Galon, Université de Paris, Sorbonne Université, Paris, France
CANCER BIOLOGY AND THE CHANGING THERAPEUTIC LANDSCAPECHAIR: SHEILA A. STEWART, WASHINGTON UNIVERSITY, ST. LOUIS, MISSOURI Tony Hunter, Salk Institute, La Jolla, California William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts Olufunmilayo I. Olopade, University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois Dennis J. Slamon, UCLA David Geffen School of Medicine, Los Angeles, CaliforniaLEVERAGING THE IMMUNE SYSTEM IN THE WAR ON CANCERCHAIR: NINA BHARDWAJ, THE TISCH CANCER INS